Mitchell was Director of Investor Relations at AstraZeneca US, and Commercial Finance at Genentech. Mitchell served as Vice President, Head of Finance and Corporate Strategy at Avalo Therapeutics.
Mitchell Chan is currently Director at Avalo Therapeutics - View - Avalo Therapeutics org chart
Create your alert
to follow the career of Mitchell Chan.
Mitchell Chan has a Strategic Finance Executive Program from University of Pennsylvania - The Wharton School and a Venture Capital Executive Program from University of California, Berkeley - Haas School of Business.
They have also studied at University of Pennsylvania - The Wharton School :
Find more alumni from University of Pennsylvania - The Wharton School
They have also studied at University of California, Berkeley - Haas School of Business :
Find more alumni from University of California, Berkeley - Haas School of Business
Do you need to know more about Mitchell Chan? More results.
Report an error
Update the org chart details of Mitchell Chan.
Sorry, but Mitchell Chan cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Mitchell Chan listed below. Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.